No, You Cannot Prescribe Any Medication to Increase Cognitive Processing Speed in Healthy Individuals
As a first-semester pharmacy student, you have no prescribing authority whatsoever, and more importantly, there are no FDA-approved medications indicated for cognitive enhancement in healthy individuals. All cognitive-enhancing drugs currently available are approved exclusively for treating pathological conditions like Alzheimer's disease, dementia, ADHD, or narcolepsy—not for boosting normal brain function.
Legal and Professional Reality
- Pharmacy students cannot prescribe medications under any circumstances
- Even licensed pharmacists in most jurisdictions have limited or no independent prescribing authority
- Prescribing requires specific licensure (MD, DO, NP, PA depending on jurisdiction)
The Evidence on "Cognitive Enhancement" in Healthy People
Cholinesterase Inhibitors (Donepezil, Rivastigmine, Galantamine)
These drugs are only indicated for dementia 1, 2. The evidence shows:
- In Alzheimer's patients, they produce modest improvements equivalent to delaying decline by approximately one year 1
- No studies support their use in healthy individuals for cognitive enhancement
- They carry significant side effects including nausea, vomiting, diarrhea, and weight loss 1, 3, 2
- Tacrine specifically causes liver toxicity in 40% of patients, requiring biweekly monitoring 1
The one exception is a small study showing donepezil helped cancer patients with chemotherapy-induced cognitive impairment 4, but this represents pathological cognitive decline, not enhancement of normal function.
Stimulants (Methylphenidate, Modafinil)
While these drugs are FDA-approved for ADHD and narcolepsy respectively, the evidence for cognitive enhancement in healthy individuals is weak and inconsistent:
Methylphenidate:
- A 2025 study found it only improved numeric working memory at 10mg, with no effect on other cognitive domains or visual scanning 5
- A 2010 review concluded the evidence for cognitive enhancement in healthy individuals is inflated and overstated 6
- The presumed benefits do not outweigh the side-effect risks in healthy people 6
Modafinil:
- One study showed improvements in digit span, visual pattern recognition, and spatial planning in healthy volunteers 7
- However, a 2011 comprehensive review concluded that effects in healthy individuals are "relatively modest" with "substantial variability" in response 8
Methamphetamine:
- A 1978 study showed it increased visual scanning speed but had no effect on more complex cognitive tasks 9
- The risk-benefit profile makes this completely inappropriate for any cognitive enhancement purpose
The Bottom Line on "Smart Drugs"
A 2025 narrative review concluded there are "relevant levels of uncertainty in terms of smart drugs' effectiveness in improving executive functions" and significant clinical concerns about non-prescribed stimulant intake by healthy individuals 10. Another 2011 review stated that experimental and clinical studies have demonstrated "relatively modest overall effects" due to substantial individual variability 8.
Why This Matters Clinically
Common pitfalls to avoid:
- Confusing disease treatment with enhancement: Drugs that help restore function in disease states (like donepezil in Alzheimer's) do not necessarily enhance normal function
- Ignoring the risk-benefit calculation: Side effects that may be acceptable when treating disease become unacceptable when there's no proven benefit in healthy people
- Falling for marketing hype: The "cognitive enhancement" narrative often exceeds what the actual evidence supports 6, 10
What Actually Works for Cognitive Performance in Healthy People
The evidence supports non-pharmacological interventions 4:
- Cognitive training: Computer-assisted rehabilitation showed significant working memory improvements (p=0.03)
- Physical exercise: Moderate to vigorous activity improved IQ scores (mean change 0.13, p=0.04) and executive function (mean change 0.23, p=0.007)
- Traditional methods like adequate sleep, caffeine, and proper nutrition remain the foundation
The most recent comprehensive review from 2026 examining phytochemical compounds (including various herbal supplements) found no benefit on processing speed, attention, working memory, language, or overall cognitive performance in healthy individuals 11.